10x Genomics’ (TXG) “Sell (E+)” Rating Reiterated at Weiss Ratings
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reissued by research analysts at Weiss Ratings in a report issued on Saturday,Weiss Ratings reports. Other equities analysts have also issued research reports about the company. Citigroup dropped their price objective on 10x Genomics from $20.00 to $15.00 and set a “buy” […]
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reissued by research analysts at Weiss Ratings in a report issued on Saturday,Weiss Ratings reports. Other equities analysts have also issued research reports about the company. Citigroup dropped their price objective on 10x Genomics from $20.00 to $15.00 and set a “buy” […]
